Psychiatry

Back to articles

Prolonged olanzapine treatment reduces the risk of psychotic depression relapse

KEY POINT

Continuing olanzapine treatment in patients with psychotic depression who were in remission reduced the risk of psychotic depression relapse compared with stopping therapy, according to a study published in JAMA. However, metabolic adverse events are increased in those who continue treatment, the study showed.